Invitae Receives Court Approval for Sale to Labcorp

Acquisition advances Labcorp’s specialty testing strategy in key areas such as oncology and rare diseases Key milestone reached in Invitae’s Chapter 11 process BURLINGTON, N.C. and SAN FRANCISCO, May 7, 2024 /PRNewswire/ — Labcorp (NYSE: LH), a global leader of innovative and…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks

ADVERTISEMENT — Advertise With Biotech Networks